The carnitine-butyrobetaine-TMAO pathway after cardiac transplant: Impact on cardiac allograft vasculopathy and acute rejection-Reference-Cited by-同舟云学术

The carnitine-butyrobetaine-TMAO pathway after cardiac transplant: Impact on cardiac allograft vasculopathy and acute rejection

Published:2019-10 Issue:10 Volume:38 Page:1097-1103
ISSN:1053-2498
Container-title:The Journal of Heart and Lung Transplantation
language:en
Short-container-title:The Journal of Heart and Lung Transplantation

Author:

Trøseid Marius,Mayerhofer Cristiane C.K.,Broch Kaspar,Arora Satish,Svardal Asbjørn^ORCID,Hov Johannes R.^ORCID,Andreassen Arne K.,Gude Einar,Karason Kristjan,Dellgren Gøran,Berge Rolf K.,Gullestad Lars,Aukrust Pål,Ueland Thor

Publisher

Elsevier BV

Subject

Transplantation,Cardiology and Cardiovascular Medicine,Pulmonary and Respiratory Medicine,Surgery

Reference27 articles.

1. Allograft vasculopathy: The Achilles’ heel of heart transplantation;Chih;J Am Coll Cardiol,2016

2. Cardiac allograft vasculopathy: Recent developments;Schmauss;Circulation,2008

3. Gut microbiota and acute coronary syndromes: Ready for use in the emergency room?;Trøseid;Eur Heart J,2017

4. Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk;Tang;N Engl J Med,2013

5. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease;Wang;Nature,2011

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intestinal Microbiota and Derived Metabolites in Myocardial Fibrosis and Postoperative Atrial Fibrillation;International Journal of Molecular Sciences;2024-05-30

2. Circulating Trimethylamine-N-Oxide Is Elevated in Liver Transplant Recipients;International Journal of Molecular Sciences;2024-05-30

3. Oral and gut microbiome alterations in heart failure: Epidemiology, pathogenesis and response to advanced heart failure therapies;The Journal of Heart and Lung Transplantation;2023-03

4. New aspects of the influence of immunity and microbiome on heart transplant rejection;Russian Journal of Cardiology;2022-09-03

5. Long-term efficacy of everolimus as de novo immunosuppressant on the cardiac allograft vasculopathy in heart transplant recipients;Atherosclerosis;2022-09